ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Sieving Named Director, National Eye Insitute.

January 19, 2001

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

In Brief: ACCC Meeting Move To Jan. 31 In Jacksonville; ACS Gynecologic Cancer Meeting Sept. 18-20 In Phila.

August 22, 1975